Clin Transl Oncol. 2008 Sep;10(9):543-51.

Therapeutic vaccines for non-Hodgkin B-cell lymphoma.

Source

Department of Clinical Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain. Jbriones@santpau.cat

Abstract

Despite current therapeutic strategies for B-cell lymphoma, including chemotherapy and transplantation, the majority of patients are not cured. The characterisation of several tumour antigens has made immunotherapy an interesting approach to the treatment of patients with lymphoma. The idiotype region in the immunoglobulin expressed by the tumour B cells is not only a clonal marker but also a tumour-specific antigen. For this reason, the idiotype is an ideal target for immunotherapy. Extensive studies of idiotype vaccination have been done in murine lymphoma models and some of these strategies are now being tested in clinical trials. In the last few years, new strategies to improve the immune response against lymphoma cells have been studied, including the use of DNA or recombinant viruses encoding tumour-antigens, genetically modified tumour cells and a number of immune adjuvants targeting dendritic cells, T cells or NK cells.

PMID:: 18796371; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Cancer Vaccines

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Lymphoma - MedlinePlus Health Information

Supplemental Content

Related citations

Review Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. [Haematologica. 2002]
Review Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA, Neelapu SS, Kwak LW, Biragyn A. Haematologica. 2002 Sep; 87(9):989-1001.
Review Vaccination as immunotherapy for B cell lymphoma. [Hematol Oncol. 1997]
Review Vaccination as immunotherapy for B cell lymphoma.
Schultze JL. Hematol Oncol. 1997 Aug; 15(3):129-39.
Review Current status of therapeutic vaccines for non-Hodgkin's lymphoma. [Curr Opin Oncol. 2005]
Review Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
Hurvitz SA, Timmerman JM. Curr Opin Oncol. 2005 Sep; 17(5):432-40.
Review Vaccination strategies in the treatment of lymphomas. [Oncology. 2002]
Review Vaccination strategies in the treatment of lymphomas.
Veelken H, Osterroth F. Oncology. 2002; 62(3):187-200.
Review Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies. [Curr Opin Investig Drugs. 2005]
Review Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
Leitch HA, Connors JM. Curr Opin Investig Drugs. 2005 Jun; 6(6):597-604.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Therapeutic vaccines for non-Hodgkin B-cell lymphoma.
Therapeutic vaccines for non-Hodgkin B-cell lymphoma.
Clin Transl Oncol. 2008 Sep ;10(9):543-51.

PubMed
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed i...
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Proc Natl Acad Sci U S A. 2007 Sep 18 ;104(38):15051-6. Epub 2007 Sep 11 .

PubMed
Fate of the leftover bladder after supravesical urinary diversion for benign dis...
Fate of the leftover bladder after supravesical urinary diversion for benign disease.
J Urol. 2006 Aug ;176(2):620-1.

PubMed
Regulation of QT indices mediated by autonomic nervous function in patients with...
Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes.
Int J Cardiol. 2004 Sep ;96(3):375-9.

PubMed
Fundamentals of phototherapy for neonatal jaundice.
Fundamentals of phototherapy for neonatal jaundice.
Adv Neonatal Care. 2006 Dec ;6(6):303-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: